Table 3.
Group | Height (cm) | Weight (Kg) | Body Fat (%) | *BMI(kg/m2) | |
---|---|---|---|---|---|
Baseline | Exp | 160.67 ± 10.66a | 65.22 ± 13.98a | 27.65 ± 7.16a | 23.43 ± 3.35a |
Placebo | 166.10 ± 09.21a | 57.23 ± 6.83a | 24.40 ± 5.22a | 22.09 ± 1.06a | |
2nd week | Exp | 160.67 ± 10.66a | 65.13 ± 14.34a | 27.53 ± 6.50a | 23.38 ± 3.46a |
Placebo | 166.10 ± 09.21a | 57.22 ± 6.65a | 24.71 ± 5.70a | 22.08 ± 1.01a | |
4th week | Exp | 160.67 ± 10.66a | 64.67 ± 13.76a | 28.48 ± 7.59a | 23.26 ± 3.23a |
Placebo | 166.10 ± 09.21a | 56.79 ± 6.57a | 24.72 ± 5.20a | 21.90 ± 1.07a | |
6th week | Exp | 160.67 ± 10.66a | 65.23 ± 14.00a | 28.26 ± 5.72a | 23.43 ± 3.32a |
Placebo | 166.10 ± 09.21a | 57.01 ± 6.97a | 25.06 ± 4.85a | 22.01 ± 1.21a | |
8th week | Exp | 160.67 ± 10.66a | 65.78 ± 14.04a | 28.42 ± 8.21a | 23.63 ± 3.35a |
Placebo | 166.10 ± 09.21a | 57.08 ± 7.02a | 24.87 ± 5.22a | 22.02 ± 1.16a | |
Follow Up (10th week) | Exp | 160.67 ± 10.66a | 65.29 ± 14.21a | 28.21 ± 7.87a | 23.44 ± 3.40a |
Placebo | 166.10 ± 09.21a | 56.99 ± 6.66a | 25.36 ± 4.62a | 22.00 ± 0.90a |
Values were expressed as means ± SD. Data within the same column of each group represented by different superscript letters were significantly different (p < 0.05).
BMI: body mass index.